Cargando…
Differentiation therapy for glioblastoma – too many obstacles?
The therapeutic potential of differentiation therapy for glioblastoma will depend on the robustness and stability of the differentiated state. We recently reported several obstacles to bone morphogenetic protein (BMP)-induced differentiation therapy. Improved understanding of the mechanisms that tum...
Autores principales: | Carén, Helena, Beck, Stephan, Pollard, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905420/ https://www.ncbi.nlm.nih.gov/pubmed/27308621 http://dx.doi.org/10.1080/23723556.2015.1124174 |
Ejemplares similares
-
The Spectre of Too Many Species
por: Leaché, Adam D, et al.
Publicado: (2019) -
Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014) -
Boosting anticancer vaccines: Too much of a good thing?
por: Ricupito, Alessia, et al.
Publicado: (2013) -
HDAC inhibitors and their potential applications to glioblastoma therapy
por: Adamopoulou, Eleni, et al.
Publicado: (2013) -
The many flavors of tumor-associated B cells
por: Marits, Per, et al.
Publicado: (2013)